Harry was Executive Vice President Vaccines R&D Strategy & External Innovation at SK Bioscience, and Senior Program Officer at Bill & Melinda Gates Foundation. Harry Kleanthous joined Apriori Bio in 2024.
Harry Kleanthous is currently
Create your alert
to follow the career of Harry Kleanthous.
Do you need to know more about Harry Kleanthous? More results.
Report an error
Update the org chart details of Harry Kleanthous.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.